🇺🇸 FDA
Pipeline program

Omomyc

VHIO23003(OMO-103-03

Phase 2 small_molecule active

Quick answer

Omomyc for Advanced High-Grade Osteosarcoma is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Advanced High-Grade Osteosarcoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials